CLASS I AND CLASS II DRUG RECALLS DURING THE PAST 12 MONTHS

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.

Drug recalls are classified by the FDA as Class I, Class II and Class III depending on the seriousness of the issue warranting the recall.

FDA Class I Recall – These are rare but the most serious type involving a dangerous or defective product that could cause serious health problems or death. These recalls will appear in the monthly bulletin for a period of one year.

FDA Class II Recall – An intermediate threat level recall issued where there is no immediate danger of death or other serious injury linked to the product, but the risk of death or a serious injury is still present.

February 14, 2024 – March 13, 2024

CLASS II

clobazam tablets, 10 mg, 100-count bottle. Manufactured by: Micro Labs Limited. Lot #: ZOAG043.

hydralazine hydrochloride tablets, 10 mg, packaged in 100-count (10x10 blister cards). Manufactured for Heritage Pharmaceuticals, Inc. Lot #: T04680, exp. date: 6/2024.

mesalamine extended-release capsules, 500 mg, 120 capsules per bottle. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: MHD0606A or MHD0612A, exp. date: 04/30/2024; Lot #: MHD0613A, MHD0652A, MHD0657A, MHD0672A or MHD0673A, exp. date: 05/31/2024; Lot #: MHD0767A, MHD0768A, MHD0769A, MHD0785A, MHD0799A, MHD0800A or MHD0801A, exp. date: 06/30/2024; Lot #: MHD0827A, MHD0828A, MHD0875A, MHD0876A, MHD0898A or MHD0901A, exp. date: 07/31/2024; Lot #: MHD1081A, MHD1082A or MHD1087A, exp. date: 09/30/2024.

January 17, 2024 – February 14, 2024

CLASS I

Zenzedi (dextroamphetamine sulfate) CII tablets, 30 mg, 30-count bottle. Manufactured for: Arbor Pharmaceuticals, LLC. Lot # F230169A, exp. date: 06/30/2025.

CLASS II

budesonide extended-release tablets, 9 mg, 30-count bottle. Manufactured by: Actavis Laboratories FL, Inc. Lot #: 100047273; exp. date: 07/2025.

cinacalcet tablets, 60 mg, 30 tablets per bottle. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: DNE0702A, exp. date: 06/30/2026.

febuxostat tablets, 40 or 80 mg, 30 tablets per bottle or carton. Distributed by: Sun Pharmaceutical Industries, Inc., or American Health Packaging. Manufactured by: Sun Pharmaceutical Industries Ltd. Lot #: DNE0866B, exp. date: 06/30/2025; Lot #: DNE1045A or DNE1046B, exp. date: 08/31/2025; Lot #: DNE0867A, exp. date: 06/30/2025; Lot #: DNE0894B, exp. date: 07/31/2025; Lot #: 1015033, exp. date: 06/30/2025; Lot #: 1016409, exp. date: 08/31/2025.

fexofenadine hydrochloride tablets; 180 mg; 30, 45 or 150 tablets per bottle. Distributed by: Ohm Laboratories Inc. or CVS Pharmacy, Inc. Lot #: DNE0792A, exp. date: 06/31/2025; Lot #: DNE1027A, exp. date: 08/31/2025; Lot #: DNE0793A, exp. date: 06/31/2025; Lot #: DNE0789A, DNE0790A or DNE0791A, exp. date: 06/2025; Lot #: DNE1026A, exp. date: 08/31/025.

ibuprofen and famotidine tablets, 800 mg/26.6 mg, 90 tablets per bottle. Manufactured by: Alkem Laboratories Ltd. Lot #: 23140190, exp. date: 12/31/2024.

lansoprazole delayed-release capsules, 15 mg, 14-count bottle. Manufactured by: Natco Pharma Limited. Lot #: 411987, exp. date: 05/2025.

lurasidone hydrochloride tablets, 60 or 120 mg, 30 tablets per bottle. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Ltd. Lot #: DNE0620A, exp. date: 05/31/2025; Lot #: DNE0621A, exp. date: 11/30/2024; Lot #: DNE0815A, exp. date: 12/31/2024.

mesalamine delayed-release tablets, 1.2 g per tablet, 120 tablets per bottle. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: DNE0875A, exp. date: 01/31/2025; Lot #: DNE0876A, DNE0877A, DNE1080A or DNE1081A, exp. date: 02/28/2025; Lot #: DNE1147A or DNE1148A, exp. date: 03/31/2025.

methoxsalen capsules, 10 mg, 50-count bottle. Manufactured by: Strides Pharma Science Ltd. Lot #: 7253092B, exp. date: 09/30/2025.

niacin extended-release tablets, 500 or 1,000 mg, 90 tablets per bottle. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: DNE0788A, exp. date: 07/31/2025; Lot #: DNE0771A, exp. date: 06/30/2025; Lot #: DNE0857A or DNE0959A, exp. date: 07/31/2025.

phenoxybenzamine hydrochloride capsules, 10 mg, 100-count bottle. Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Lot #: AM221153, exp. date: 06/30/2024; Lot #: AM230497, exp. date: 02/29/2025.

rifampin capsules, 150 or 300 mg, 30-count bottle. Manufactured for: Lupin Pharmaceuticals, Inc., or Distributed by: American Health Packaging. Lot #: A200816, exp. date: 1/2024; Lot #: A201248, exp. date: 3/2024; Lot #: A200817, exp. date: 1/2024; Lot #: 1008111, exp. date: 01/31/2024.

zolpidem tartrate extended-release tablets, 6.25 or 12.5 mg, 100 tablets per bottle. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: DNE0892A, exp. date: 07/31/2026; Lot #: DNE0893A, exp. date: 07/31/2026.

December 14, 2023 – January 17, 2024

CLASS I

CLASS II

allopurinol tablets, 300 mg, 500 tablets per bottle. Manufactured by: Dr. Reddy's Laboratories LA LLC. Batch L100813.

amoxicillin tablets, 875 mg, 20 tablets, Manufactured by: Sandoz GmbH for Sandoz Inc. Batch LJ9004.

aripiprazole tablets, 5 mg, 30 tablets per bottle. Distributed by: Amneal Pharmaceuticals LLC. Batch AR202318.

ARMOUR THYROID tablets, 2 GRAIN (120 mg), 100 tablets. Distributed by: Allergan US, Inc. Batch W05543.

bumetanide tablets, 2 mg, 100 tablets per bottle. Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Batch AM211171.

bupropion hydrochloride extended-release tablets, 150 mg, 30-count bottles. Manufactured for: Rising Pharma Holdings, Inc. Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Lot #: BPA123098A, exp. date: 06/2025.

chlorthalidone tablets, 25 mg, 1,000 tablets. Manufactured by: Appco Pharma LLC. Batch 2107329UM.

citalopram tablets, 20 mg, 100 tablets. Manufactured for: Mylan Pharmaceuticals Inc. Batch 3131748.

desloratadine tablets, 5 mg, 100s pack and 500s pack. Manufactured for: Lupin Pharmaceuticals, Inc. Lot #: G201822, exp. date: Jan 2024, 100 count; Lot #: G201823, exp. date: Jan 2024, 100 count; Lot #: G201824, exp. date: Jan 2024, 500 count.

dicyclomine hydrochloride tablets, 20 mg, 100 tablets. Manufactured For: Teva Pharmaceuticals USA. Batch 3197790.

donepezil HCl tablets, 5 or 10 mg, 90 tablets. Distributed by: Solco Healthcare U.S. LLC. Batch 17616 or Batch 17605.

doxycycline capsules, 100 mg, 50 capsules. Manufactured for: Lupin Pharmaceuticals, Inc. Manufactured by: Lupin Limited. Batch G104819.

estradiol tablets, 0.5 mg, 100 tablets. Teva Pharmaceuticals USA, Inc. Batch 100023687.

folic acid tablets, 1 mg, 100 tablets per bottle. Manufactured by: Leading Pharma, LLC. Batch H08221. hydralazine hydrochloride tablets, 25 mg, 100 tablets per bottle. Distributed by: Avet Pharmaceuticals Inc. Batch G210553 or G210551.

Jardiance (empagliflozin) tablets, 25 mg, 30 tablets (3 blister cards with 10 tablets each). Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc. Batch D41919. Leader Nasal Decongestant PE (phenylephrine HCl) tablets, 10 mg, 18 tablets per cartons. Distributedby: Cardinal Health. Batch P125514.

Lillow (levonorgestrel and ethinyl estradiol) tablets, 0.15 mg/0.03 mg, 1 blister pack containing 28 tablets. Distributed by: Amneal Pharmaceuticals LLC. Batch A5921.

liothyronine sodium tablets, 5 mcg, 100-count bottle. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Ltd. Lot #: DND0059A, exp. date: 12/2023; Lot #: DND0060A, exp. date: 12/2023; Lot #: DND0061A, exp. date: 12/2023; Lot #: DND0062A, exp. date: 01/2024; Lot #: DND0063A, exp. date: 01/2024; Lot#: DND0064A, exp. date: 01/2024; Lot #: DND0065A, exp. date: 01/2024; Lot #: DND0180A, exp. date: 01/2024; Lot #: DND0181A, exp. date: 01/2024; Lot #: DND0182A, exp. date: 01/2024; Lot #: DND0183A, exp. date: 01/2024; Lot #: DND0184A, exp. date: 01/2024; Lot #: DND0597A, exp. date: 02/2024.

lisinopril and hydrochlorothiazide tablets, 10mg/12.5mg, 100 tablets per bottle. Manufactured for: Lupin Pharmaceuticals, Inc. Manufactured by: Lupin Limited. Batch Q101699 or Q101981.

lithium carbonate extended-release tablets, 300 mg, 100 tablets per bottle. Manufactured for: Mylan Pharmaceuticals Inc. Batch 3138326.

low dose ASPIRIN, 81 mg, 120 enteric-coated tablets. Distributed by: Rugby Lavoratories. Batch P126201.

meloxicam tablets, 15 mg, 1,000 tablets per bottle. Manufactured by: Cipla Ltd. Batch KA11489.

metoprolol succinate extended-release tablets, 50 mg, 1,000 Tablets. Teva Pharmaceuticals USA, Inc. Batch 2447J211.

penicillamine tablets, 250 mg, 100-count bottle. Manufactured for: Lupin Pharmaceuticals, Inc. Manufactured by: Lupin Limited. Lot #: M200498, exp. date: June 2024.

prednisone tablets, 20 mg, 100 tablets per bottle. Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Batch 21P0659.

propranolol hydrochloride tablets, 20 mg, 100 tablets per bottle. Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Batch 100023596.

sertraline tablets, 100 mg, 30 tablets per bottle. Distributed by: Wal-Mart. Manufactured for: Cipla USA, Inc. Lot #: 222033, exp. date: 08/31/2024.

tacrolimus capsules, 1 mg, 100-count bottles. Manufactured by: Dr. Reddy's Laboratories Limited. Lot #: C2307275; exp. date: January 2026.

tizanidine tablets, 4 mg, 150-count bottle. Manufactured by: Dr. Reddy's Laboratories Limited. Lot #: T2304007, exp. date: 7/31/2026.

triamterene and hydrochlorothiazide capsules, 37.5 mg/25 mg, 100 capsules per bottle. Distributed by: Lannett Company, Inc. Batch 21000279A or 21000280A.

warfarin sodium tablets, 2.5 or 5 mg, 100 tablets per bottle. Manufactured for: Teva Pharmaceuticals. Batch 2169041 or 2323041.

November 14, 2023 – December 14, 2023

CLASS I

Dr. Ergin’s SugarMD Advanced Glucose Support capsules, 60-count, 120-count and 180-count bottles. Manufactured for: SugarMDs LLC. Lot #: 22165-003, exp. date: 09/2024.

Polyvinyl Alcohol, 1.4% lubricating eye drops, packed in 0.5 FL OZ (15 mL) dropper bottles. Distributed by: Rugby Laboratories. All lots.

Leader Brand Dry Eye Irritation Relief, 0.5 FL OZ (15 mL) dropper bottles. Distributed by: Cardinal Health. All lots.

Leader Brand Dry Eye Relief, 0.33 FL OZ (10 mL) dropper bottles. Distributed by: Cardinal Health. All lots.

Leader Brand Lubricant Eye Drops, 0.5 FL OZ (15 mL) and 0.33 FL (10 mL) dropper bottles. Distributed by: Cardinal Health. All lots.

Lubricant Tears Eye Drops, 0.5 FL OZ (15 mL) bottles. Distributed by: Rugby Laboratories. All lots.

CLASS II

Indomethacin capsules, 25mg, 100-count bottles. Manufactured by: Glenmark Pharmaceuticals Ltd. Lots #19231903, 19231858, 19231881, exp. date: 04/2025. Lots #:19233484, 19233490, exp. date: 08/2025.

Naproxen tablets, 250 mg, 100-count bottle. Manufactured by: Glenmark Pharmaceuticals Ltd. Lots #: 19231903, 19231858, 19231881, exp. date: 04/2025. Lots #: 19233484, 19233490, exp. date: 08/2025.

Paroxetine tablets, 10 mg, 20 mg or 40 mg, 30-count bottles, 90-count bottles and 1000-count bottles. Manufactured by: Apotex inc. Lots #: GS041383, GS040841, GS041384, GS042039, GS040910, GS041621, GS042237, GS036696, GS037068, GS037934, GS038564, GS036381, GS036712, GS037116, GS037692, GS038388, GS036488, GS037091, GS037701, GS037090, GS037702, GS036677, GS037117, GS037699, exp. date: 08/2024.

Paroxetine Hydrochloride tablets, 10 mg, 20 mg, 30 mg or 40 mg, 30-count bottles, 100-count bottles and 1000-count bottles. Manufactured by: Apotex Inc. Lots# RV2376, RV2377, RV2379, RV238, RV2375, RV2384, RV2385, RV2396, RV2397, RV8686, RX0119, RV2254, RV0131, RV2388, exp. date: 08/2024.

Penicillamine tablets, 250 mg, 100-count bottles. Manufactured by: Lupin Pharmaceuticals, Inc. Lot 3: M200498, exp. 06/2024.

Trospium Chloride Extended-Release capsules, 60 mg, 30 capsules per bottle. Manufactured by: Sidmak Laboratories (India) Pvt. Ltd. Lots #: 231104, 231105, 231106, exp. date: 07/2025.

October 11, 2023 – November 14, 2023

CLASS I

Betaxolol tablets, 10 mg, 100-count bottles. Manufactured by: KVK Tech Inc. Lot #: 17853A, exp. date: 06/27.

CLASS II

Deferasirox tablets for oral suspension, 500 mg, 30-count bottles. Manufactured for: Glenmark Pharmaceuticals Inc. Lot #: 17220063, exp. date: 12/23; Lots #17220396, 17220397, exp. date: 04/24; Lot #17220965, exp. date: 04/24; Lots #17221187, 17221523, exp. date: 07/24; Lots #17221793, 17221794, 17221801, exp. date: 08/24.

Liothyronine Sodium tablets, 5mcg or 25mcg, 100-count bottles. Manufactured and distributed by: Sun Pharmaceutical Industries Ltd. Lot #: DND0058A, exp. date: 12/23; Lot #DNC2204A, exp. date: 11/23.

Montelukast Sodium tablets, 10 mg, 1000-count bottle. Distributed by: Dr. Reddy’s Laboratories. Lot #: C2305569, exp. date: 03/26.

Oxybutynin Chloride extended-release tablets, 5 mg, 10 mg or 15 mg, 100-count bottles. Manufactured by: Cadila Healthcare Ltd. Distributed by: Zydus Pharmaceuticals (USA) Inc. Lots #M212749, M214477, M214478, M214479, M214480, exp. date: 11/24; Lots # M213318, M213314, M213315, M214436, M214437, M214438, M300653, M300654, exp. date: 12/24; Lots #: M211541, M211542, M212746, exp date. 10/24; Lot # M300660, exp. date: 12/24.

Ranolazine extended-release tablets, 500 mg, 60 tablets per bottle. Manufactured by: Glenmark Pharmaceuticals Limited. Lot #: 17230388, exp. date: 01/25.

TUMS Antacid Calcium Carbonate, 1000 mg, peppermint flavor, chewable tablets, 72-count bottle or 12-count roll. Distributed by: GSK CH. Lot #: HB2G, exp. date: 08/27; Lot #: HA7G, exp. date: 08/27.

TUMS Antacid Calcium Carbonate, 1000 mg, assorted fruit flavor, chewable tablets, 106-count bottles. Distributed by: GSK CH. Lot #: HV6B, exp. date: 09/27.

TUMS Antacid Calcium Carbonate, 1000 mg, assorted berries flavor, chewable tablets, 72-count bottles, 12-count rolls or 265-count bottles. Distributed by: GSK CH. Lot #: HR5W, exp. date: 09/27; Lot #: HR6A, exp. date: 09/27; Lot #: J96X, J96W, exp. date: 09/27; Lot #: KH5L, exp. date: 09/27.

September 13, 2023 – October 11, 2023

CLASS II

Rufinamide tablets, 200 mg or 400 mg, 120-count bottle. Distributed by: Aurobindo Pharma USA, Inc. Lot #: RB2023001A, exp. date: 02/25; Lot #: RB4023002A, exp. date: 02/25.
 

CLASS I

Brexafemme tablets, 150 mg, 4 count cartons. Manufactured for and distributed by: Scynexis, Inc. Lot #: LF21000008, exp. date: 11/23; Lot #: LF22000051, exp. date: 11/25.

Digoxin tablets, 0.125 mg, 100-count bottles. Manufactured for/distributed by: Marlex Pharmaceuticals, Inc. Lot #: E3810, exp. date: 02/25; Lot #: E3811, exp. date: 02/25.

Wefun capsules, 825 mg, 1X10 blister pack per carton. Manufactured by: Wefun Inc. Lot #: 18520168, exp. date: 09/26.

CLASS II

Digoxin tablets, 0.25 mg, 100-count bottles. Manufactured for/distributed by: Marlex Pharmaceuticals, Inc. Lot #: E3811, exp. date: 02/25.

Oxybutynin Chloride Extended-Release tablets, 10 mg, 100 tablet and 500 tablet bottles. Manufactured by: Cadila Healthcare Ltd. Lot #: M300652 and M300651, exp. date: 12/24.

Rasagiline tablets, 0.5 mg, 30-count bottle. Manufactured by: Mylan Pharmaceuticals Inc. Lot #: 3112444, exp. date: 08/23.

August 16, 2023 – September 13, 2023

CLASS II

Rufinamide tablets, 200 mg or 400 mg, 120-count bottle. Distributed by: Aurobindo Pharma USA, Inc. Lot #: RB2023001A, exp. date: 02/25; Lot #: RB4023002A, exp. date: 02/25.

July 12, 2023 – August 16, 2023

CLASS I

CLASS II

aller-ease, fexofenadine hydrochloride tablets, 180 mg, 30-count cartons. Packaged For: Your Military Exchanges, By: Perrigo Company. Lot #: 2ER0285, exp. date: 01/24.

Allergy, fexofenadine hydrochloride tablets; 180 mg; packaged in 15-, 30- or 150-count cartons. Distributed By: Amazon.com Services LLC, Adusa Distribution LLC or CVS Pharmacy, Inc. Lot #: 2GR0329, exp. date: 04/24; Lot #: 2DR0472, exp. date: 02/23; Lot #: 2MR0417, exp. date: 07/24; Lot #: 2JE2185, exp. date: 01/24; Lot #: 2DV1925, exp. date: 06/23.

Allergy ALLER-FEX, fexofenadine hydrochloride tablets, 180 mg, 180-count cartons. Packaged by: Perrigo. Lot #: 2DV1487, 2DV1870, 2DV1871, 2DV1873, 2EV1676, 2GV2132 or 2HV2679, exp. date: 12/23; Lot #: 2DV2000, exp. date: 11/23; Lot #: 2LV1573 or 2MV1314, exp. date: 04/24; Lot #: 2FV1764, 2FV1765 2FV1766, 2GV1579, 2GV1937, 2GV1941 , 2GV1942, 2GV2157, 2HV1886, 2HV1997, 2HV2019 or 2HV2047, exp. date: 02/24; Lot #: 2EV1666, 2EV1667, 2EV1668, 2EV1670, 2EV1671, 2EV1672, 2EV1674, 2EV1677, 2EV1678 or 2HV2017, exp. date: 01/24.

allergy relief, fexofenadine hydrochloride tablets; 180 mg; packaged in 15-, 30-, 45-, 70-, 90- or 150-count cartons. Distributed by: MEIJER DISTRIBUTION INC, Target Corporation or Topco Associates LLC. Lot #: 2JE1882, exp. date: 01/24; Lot #: 2FV1918 or 2ER0411, exp. date: 01/24; Lot #: 2GV1902, exp. date: 04/24; Lot #: 2CR0652 or 2DR0465, exp. date: 12/23; Lot #: 2GR0329, exp. date: 04/24; Lot #: 2CR0653 or 2DR0466, exp. date: 12/23; Lot #: 2ER0287 or 2ER0412, exp. date: 01/24; Lot #: 2HE2032, 2JE1882 or 2JE2185, exp. date: 01/24; Lot #: 2DR0464 or 2ER0410, exp. date: 12/23; Lot #: 2ER0286 or 2ER0411, exp. date: 01/24; Lot #: 2DR0467, 2DR0468, 2DR0469 or 2ER0288, exp. date: 12/23; Lot #: 2ER0414, exp. date: 01/24; Lot #: 2GR0333, exp. date: 02/24; Lot #: 2FV1948, 2ER0285 or 2ER0411, exp. date: 01/24; Lot #: 2CR0653, exp. date: 12/23; Lot #: 2GR0331, exp. date: 04/24.

allergyrelief, fexofenadine hydrochloride tablets, 180 mg, packaged in 30- or 45-count cartons. Distributed by: Publix Super Markets, Inc. Lot #: 2CR0652, 2DR0464 or 2DR0465, exp. date: 12/23; Lot #: 2ER0285, exp. date: 01/24; Lot #: 2DR0466, exp. date: 12/23; Lot #: 2ER0412, exp. date: 01/24; Lot #: 2GR0330, exp. date: 04/24.

Famotidine tablets, 20 mg, 200-count bottle within a carton. Distributed by: Glenmark Therapeutics Inc. Lot #: FA2022001B, exp. date: 03/2025.

Fexofenadine hydrochloride tablets; 180 mg; 30-, 45- or 100-count cartons. Distributed by: Perrigo. Lot #: 2DR0351, exp. date: 12/23; Lot #: 2DV1869, 2EV1613 or 2EV1614, exp. date: 12/23; Lot #: 2EV1820 or 2FV1943, exp. date: 01/24; Lot #: 2GV1893, exp. date: 04/24. Lot #: 2CR0653 or 2DR0466, exp. date: 12/23; Lot #: 2ER2087, exp. date: 01/24.

Fingolimod capsules, 0.5 mg, 30-count bottle. Manufactured by: Alkem Laboratories Ltd. Lot #: 22122841, exp. date: August 2025.

Methylphenidate hydrochloride tablets, 20 mg, 100 tablets per bottle. Manufactured by: Ohm Laboratories Inc. Lot #: AC74459, exp. date: 07/31/2024.

Non-Drowsy Allergy Relief, fexofenadine hydrochloride tablets, 180 mg, 150-count cartons. Distributed by: BJ's Wholesale Club. Lot #: 2DV1863 or 2HV2698, exp. date: 12/23; Lot #: 2GV1583, exp. date: 02/24; Lot #: 2GV1950 or 2HV2697, exp. date: 01/24.

Picnic, fexofenadine hydrochloride tablets, 180 mg, 90-count cartons. Distributed by: Thirty Madison, Inc. Lot #: 2DR0471, exp. date: 12/23.

Sunitinib malate capsules, 12.5 mg, 28-count bottles. Manufactured by: Teva Pharmaceuticals USA, Inc. Lot #: 100037220, exp. date: 10/2024.

Tiagabine hydrochloride tablets, 2 mg, 30-count bottle. Distributed by: Sun Pharmaceutical Industries. Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: HAC3339A, exp. date: 07/2023.

Tizanidine tablets, 4 mg, 1,000-count bottle. Manufactured by: Dr. Reddy's Laboratories Limited. Lot #: T2100585, T2100586 or T2100587, exp. date: 12/2023.

Tydemy (drospirenone, ethinyl estradiol and levomefolate calcium) tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets 0.451 mg, packaged in 1 blister of 28 tablets each, further packaged in a carton of 3 blisters. Distributed by: Lupin Pharmaceuticals, Inc. Manufactured by Lupin Limited. Lot #: L200183, exp. date: 1/2024; Lot #: L201560, exp. date: 9/2024.

June 14, 2023 – July 12, 2023

CLASS I

Ziprasidone hydrochloride capsules, 20 mg, 40 capsules. Manufactured by: Dr. Reddy's Laboratories Limited. Lot #: T04769, exp. date: 12/2024.

CLASS II

Extended phenytoin sodium capsules, 100 mg, 100 capsules per bottle. Distributed by: Amneal Pharmaceuticals LLC. Lot #: HL00721A, exp. date: 12/2023.

Losartan potassium tablets, 25 mg, 1,000 film-coated tablets per bottle. Manufactured by: Vivimed Life Sciences Private Limited. Lot#: 7901903A, exp. date: 04/2024.

Tizanidine tablets, 4 mg, 100 tablets (10 tablets x 10 unit dose blister packs) per carton. Packaged and Distributed by: American Health Packaging. Lot #: 1004835, exp. date: 7/31/2023.

Tizanidine hydrochloride tablets; 4 mg; packaged in 20-, 30-, 60-, 90- or 120-count bottles. Manufactured by: Dr. Reddy's Laboratories Limited. Lot #: H1621S, exp date: 12/31/2023; Lot #: H2321C, exp. date: 12/31/2023; Lot #: H0421B, exp. date: 12/31/2023; Lot #: H1721E, H1921T or H3121M, exp. date: 12/31/2023; Lot#: H2021G, exp. date: 12/31/2023.

Tramadol hydrochloride tablets, 50 mg, 100-count tablets. Manufactured by: Sun Pharmaceutical Industries Ltd. Lot #: M04343, exp. date: 04/2024.

May 11, 2023 – June 14, 2023

CLASS II

Acetaminophen caplets, 500 mg, 225-count bottles. Distributed by: Walgreen Co. Lot #: P2200101 or P2200178, exp. date: 11/2023; Lot #: P2200230, exp. date: 12/2023.

buPROPrion hydrochloride extended-release tablets, 150 mg, 60 tablets. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: HAC2240A, exp. date: 05/2023; Lot #: HAC3162A, exp. date: 07/2023.

Glimepiride tablets; 1, 2 or 4 mg; 100- or 500-count bottle. Manufactured by: Intas Pharmaceuticals Limited. Lot #: P2002616, exp. date: 04/30/2023; Lot #: P2006509, exp. date: 11/30/2023; Lot #: P2103572, exp. date: 04/30/2024; Lot #: P2106811, exp. date: 09/30/2024; Lot #: R2200578, exp. date: 04/30/2025; Lot #: P2100095, exp. date: 11/30/2023; Lot #: P2100624, exp. date: 01/31/2024; Lot #: P2101780, exp. date: 02/29/2024; Lot #: P2107383, exp. date: 09/30/2024; Lot #: P2201505, exp. date: 02/28/2025; Lot #: R2201109, exp. date: 06/30/2025; Lot #: P2003493, exp. date: 05/31/2023; Lot #: P2100120, exp. date: 11/30/2023; Lot #: P2100683, exp. date: 01/31/2024; Lot #: P2106002, exp. date: 07/31/2024; Lot #: R2200148, exp. date: 12/31/2024; Lot #: R2201125, exp. date: 06/30/2025; Lot #: P2003403, exp. date: 05/31/2023; Lot #: P2005800, exp. date: 09/30/2023; Lot #: P2101156, exp. date: 01/31/2024; Lot #: P2105401, exp. date: 07/31/2024; Lot #: R2200083, exp. date: 12/31/2024; Lot #: R2201004, exp. date: 07/31/2025; Lot #: P2003403, exp. date: 05/31/2023; Lot #: P2006593, exp. date: 11/30/2023; Lot #: P2101152, exp. date: 01/31/2024; Lot #: P2105014, exp. date: 06/30/2024; Lot #: R2101440, exp. date: 09/30/2024; Lot #: P2200774, exp. date: 01/31/2025; Lot #: R2200664, exp. date: 04/30/2025; Lot #: P2100705, exp. date: 01/31/2024; Lot #: P2104672, exp. date: 06/30/2024; Lot #: R2101435, exp. date: 09/30/2024; Lot #: R2200102, exp. date: 12/31/2024; Lot #: R2200577, exp. date: 04/30/2025; Lot #: P2205870, exp. date: 08/31/2025; Lot #: P2100121, exp. date: 11/30/2023; Lot #: P2100705, exp. date: 01/31/2024; Lot #: P2104672, exp. date: 06/30/2024; Lot #: R2101435, exp. date: 09/30/2024; Lot #: R2200102, exp. date: 12/31/2024; Lot #: R2200577, R2200577 or P2205870, exp. date: 08/31/2025.

Rifampin capsules, 150 or 300 mg, 30- or 60-count bottles. Distributed by: Akorn Operating Company LLC. All Lots.

April 12, 2023 – May 10, 2023

CLASS II

Advil (ibuprofen) tablets; 200 mg; packaged in 24-, 50- or 100-count bottles or 3 (2-count) packets. Family Dollar Stores. Lot #: 0901458, 0913023, 0999259 or 0901839, stored and distributed from DCs 07/28/2022 through 03/31/2023.

Advil Dual Action with Acetaminophen tablets, 125 mg/250 mg, 36-caplet bottles. Family Dollar Stores. Lot #: 0902867, stored and distributed from DCs 07/28/2022 through 03/31/2023.

Advil Liqui-Gels (solubilized ibuprofen) capsules, 200 mg, 20- or 40-count liquid-filled-capsule bottles. Lot #: 0999841 or 0916071, stored and distributed from DCs 07/28/2022 through 03/31/2023.

Aripiprazole tablets, 20 mg, packaged in 500-count bottles. Manufactured by: Alkem Laboratories Ltd. Lot #: 22143120, exp. date: June 2024.

Atorvastatin calcium tablets, 10 mg, 30-count bottles. Repackaged by: Northwind Pharmaceuticals. Lot #: F117192201, exp. date: Date 4/30/2023.

BusPIRone hydrochloride tablets, 7.5 mg, 30-count bottles. Repackaged by: NOrthwind Pharmaceuticals. Lot #: F117312201, exp. date: 06/30/2024.

Doxazosin tablets, 4 mg, 30-count bottles. Repackaged by: Northwind Pharmaceuticals. Lot #: F107752201, exp. date: 05/31/2024.

Glimepiride tablets, 2 or 4 mg, 30- or 90-count bottles. Repackaged by: Northwind Pharmaceuticals or Intas Pharm. Limited. Lot #: F106252201, exp. date: 09/30/2024; Lot #: F106252301 or F106252303, exp. date: 5/31/2025; Lot #: F106252304, exp. date: 07/31/2025; Lot #: F106252302, exp. date: 07/31/2025; Lot #: F105692201, exp. date: 09/30/2024; Lot #: F105692203, exp. date: 02/28/2025; Lot #: F105692202, exp. date: 02/28/2025; Lot #: A22B45, exp. date: 01/31/24; Lot #: C22A73, E22E41, C22D28, F22B68, G22A29, H22B97 or K22A36, exp. date: 03/31/24; Lot #: K22B99, A23D07 or B23B25, exp. date: 10/31/24; Lot #: B23B55, exp. date: 06/30/25.

Montelukast sodium, 10 mg, 30 count-bottles. Intas Pharm, Limited. Lot #: L22C80, I22D93 or K21C72, exp. date: 11/30/23; Lot #: A23A90 or B23A09, exp. date: 07/31/24; Lot #: K22C33, exp. date: 05/31/24; Lot #: G22E88, G22F66, I22E27, C22B27, D22B94 or E22C71, exp. date: 02/28/24; Lot #: I21E36, exp. date: 09/30/23.

Pantoprazole sodium delayed release tablets, 40 mg, 1,000-count bottles. Manufactured for: Camber Pharmaceuticals Inc. Lot #: PAN22542, exp. date: 9/2024.

Simvastatin; 10, 20 or 40 mg. Intas Pharm, Limited. Lot #: K22E32, exp. date: 10/31/23; Lot #: H22C33, exp. date: 09/30/23; Lot #: H22C81, J22C83 or K22E36, exp. date: 10/31/23; Lot #: G22B32, D22B92 or D22F82, exp. date: 06/30/23; Lot #: G22F41, J22F25 or L22C14, exp. date: 01/31/24; Lot #: D22B92 or D22F82, exp. date: 06/30/23; Lot #: B22A12, exp. date: 03/31/23; Lot #: H22A32, I22E83, J22E94 or K22E34, exp. date: 01/31/24; Lot #: C22F31, D22G16, E22D75 or F22E06, exp. date: 06/30/23; Lot #: L21E09 or B22C61, exp. date: 01/31/23; Lot #: A22A17 or D22C21, exp. date: 07/31/23; Lot #: K22D89, L22B26 or L22D14, exp. date: 03/31/24; Lot #: L22D96, exp. date: 04/30/24; Lot #: L21E06, exp. date: 05/31/23; Lot #: B22C05, D22B91 or E22C82, exp. date: 07/31/23; Lot #: G22B03 G22B79, H22A30 or J22B81, exp. date: 08/31/23; Lot #: J22F27, K22B37 or K22B88, exp. date: 10/31/23; Lot #: L22D32, exp. date: 03/31/24; Lot #: B23E07, exp. date: 04/30/24.

Tadalafil tablets; 5 or 20 mg; 6-, 15- or 30-count bottles. Repackaged by: Northwind Pharmaceuticals. Lot #: F113892002, exp. date: 08/31/2023; Lot #: F113892201, exp. date: 11/30/2023; Lot #: F113892001, exp. date: 08/31/2023; Lot #: F113892202, exp. date: 11/30/2023; Lot #: F113892203, exp. date: 12/31/2023; Lot #: F114302001, exp. date: 05/31/2023.

Verapamil hydrochloride extended-release tablets, 180 mg, 100 tablets (10 x 10) per carton. Distributed by: American Health Packaging. Lot #: 1008622 or 1010026, exp. date: 2/29/24.

March 15, 2023 – April 12, 2023

CLASS I

CLASS II

Alprazolam tablets; 0.25, 0.5, 1 or 2 mg; 30-, 60- or 90-count bottle. Manufactured by: Breckenridge Pharmaceuticals, Inc., or Packaged and Distributed By: Direct Rx. Lot #: G1822K, exp. date: 5/31/2023; Lot #: D2022P, exp. date: 4/30/2023; Lot #: F1022Y, E2022 or I2822U, exp. date: 6/30/2023; Lot #: L2122W, exp. date: 8/31/2024; Lot #: L0522A, exp. date: 8/31/2024; Lot #: B0823J, exp. date: 11/31/2024; Lot #: L1522P, exp. date: 10/31/2024; Lot #: H3122D, exp. date: 8/31/2024; Lot #: A1123R, L0522E, J2622H, I1622F or H2422E, exp. date: 8/31/2024; Lot #: 11AP2219, exp. date: 4/30/23; Lot #: 03FE2318, exp. date: 8/31/24; Lot #: 27FE2315, 28FE2313, 02MA2306, 21SE2201, 16NO2216, 17NO2216 or 24FA2314, exp. date: 8/31/24; Lot #: 17FE2203, 12AP2204 or 17MA2205, exp. date: 3/31/23; Lot #: 21JU2206, 22JU2220 or 12JY2206, exp. date: 5/31/23; Lot #: 10AU2209, exp. date: 6/30/23; Lot #: 14DE2215, exp. date: 9/30/24; Lot #: 05JA2304 or 27JA2301, exp. date: 11/30/24; Lot #: 03FE2319, exp. date: 2/28/25, Lot #: 13MY2217, exp. date: 5/31/23.

Aripiprazole tablets, 5 mg, 30-count bottles. Repackaged by: RemedyRepack Inc. Lot #: J0620431-052322, exp. date: 05/31/23.

Atorvastatin calcium tablets, 10 or 20 mg, 30- or 90-count bottle. Manufactured by: Accord Healthcare, Inc., or Repackaged by: RemedyRepack Inc. Lot #: A0523D, exp. date: 5/31/2024, Lot #: F14220, exp. date: 7/31/2023; Lot #: J0622Q, exp. date: 1/31/2024; Lot #: B1522B, exp. date: 4/30/2023; Lot #: C0222H or C0322B, exp. date: 5/31/2023; Lot #: E1022H, F13220 or H2222P, exp. date: 6/30/2023; Lot#: I1422V or K01220, exp. date: 12/31/2023; Lot #: L2722H, exp. date: 3/31/2024; Lot #: C0322B, exp. date: 5/31/2023; Lot #: H1122G or 12322Q, exp. date: 6/30/2023; Lot #: J1222U, exp. date 12/31/2023; Lot #: J0679046-020123, exp. date: 02/28/2024; Lot #: J0669807-122122, exp. date: 01/31/2024; Lot #: J0662695-112222, exp. date: 12/31/2023; Lot #: J0654076-101822 or J0654076-101822, exp. date: 11/30/2023; Lot #: J0642765-082922, exp. date: 09/30/2023; Lot #: B1672408-050322, B1765902-071322 or B1769634-071622, exp. date: 04/30/2023; Lot #: B1776907-072122, exp. date: 09/30/2023; Lot #: B1836636-090322, exp. date: 11/30/2023; Lot #: B1870344-092422, exp. date: 01/31/2024; Lot #: B1908452-101522, B1966455-111722 or B2043099-010423, exp. date: 05/31/2024; Lot #: J0659819-110922, exp. date: 11/30/2023; Lot #: J0649932-093022 or J0649917-093022, exp. date: 10/31/2023, Lot #: B2010060-121222, exp. date: 03/31/24; Lot #: B1708575-060122, exp. date: 05/31/2023; Lot #: B1879236-092922, exp. date: 12/31/2023.

Clopidogrel tablets, 75 mg, 90-count bottles. Manufactured: Accord Healthcare, Inc. Lot #: E0922W, G1222E, I0922W or K3022W, exp. date: 10/31/2023.

Dabigatran etexilate capsules, 75 or 150 mg, 60 capsules per bottle. Manufactured by: Alkem Laboratories Ltd. Lot #: 22142462, 22142463 or 22142464, exp. date: 5/2024; Lot #: 22143000, 22143001 or 22143002, exp. date: 6/2024; Lot #: 22142448, 22142449 or 22142450, exp date: 5/2024; Lot #: 22143845, exp. date: 7/2024.

Doxazosin tablets; 2 or 4 mg; 30-, 90- or 100-count bottle. Manufactured by: Accord Healthcare, Inc., or Repackaged by: RemedyRepack Inc. Lot #: H3122K, exp. date: 5/31/2024; Lot #: L1522V, exp. date: 4/30/2025; Lot #: J0665197-120522, exp. date: 12/31/2023; Lot #: J0642497-082722, exp. date: 09/30/2023; Lot #: J0638552-080922, exp. date: 08/31/2023; Lot #: B1808799-081622, exp. date: 05/31/2024.

Finasteride tablets, 5 mg, 30- or 90-count bottle. Packaged and Distributed By: Direct Rx or Manufactured by: Accord Healthcare, Inc. Lot #: 19AU2205, exp. date: 12/31/24; Lot #: 12OC2211, exp. date: 12/31/24; Lot #: A1321V or D0221J, exp. date: 8/31/2023; Lot #: A1322J, exp. date: 5/31/2024; Lot #: F0221Q, I0121E, I1021R or J1122D, exp. date: 10/31/2023; Lot #: B0422J, exp. date: 5/31/2024; Lot #: C1721K, exp. date: 8/31/2023; Lot #: K1022Q, exp. date: 11/30/2024.

Glimepiride tablets; 1, 2 or 4 mg; 30-, 90- or 180-count bottle. Packaged and Distributed By: Direct Rx or Manufactured by: Accord Healthcare, Inc.. Lot #: 07MA2208, exp. date: 5/31/2024; Lot #: 09AU2128, exp. date: 1/31/2024; Lot #: 28JY2102, exp. date: 1/31/2024; Lot #: 06AU2103, exp. date: 1/31/2024; Lot #: 03JA2210, exp. date: 1/31/2024; Lot #: 14JY2114, exp. date: 1/31/2024; Lot #: 05NO2106, exp. date: 2/29/2024; Lot #: 13OC2118, exp. date: 2/29/2024; Lot #: 08DE2121, exp. date: 2/29/2024; Lot #: 21JU2112, exp. date: 9/30/2023; Lot #: 22DE2113, exp. date: 1/31/2024; Lot #: 27JA2235, exp. date: 3/31/2024; Lot #: 05AP2224, exp. date: 7/31/2024; Lot #: 06AU2104, exp. date: 1/31/2024; Lot #: 08JU2215, exp. date: 9/30/2024; Lot #: 209AU2109, exp. date: 1/31/2024; Lot #: 15JU2113, exp. date: 9/30/2023; Lot #: 21FE2217, exp. date: 4/30/2024; Lot #: 21OC2115, exp. date: 2/29/2024; Lot #: 23JY2144, exp. date: 1/31/2024; Lot #: 25JU2124, exp. date: 9/30/2023; Lot #: 29AP2219, exp. date: 7/31/2024; Lot #: 07DE2128, exp. date: 3/31/2024; Lot #: 13DE2111, exp. date: 3/31/2024; Lot #: 17NO2116, exp. date: 1/31/2024; Lot #: 27JA2234, exp. date: 4/30/2024; Lot #: 02MA2218, exp. date: 6/30/2024; Lot #: 12MY2211, exp. date: 7/31/2024; Lot #: 13JY2107, exp. date: 10/31/2023; Lot #: 15AP2221, exp. date: 7/31/2024; Lot #: 17AU2110, exp. date: 10/31/2023; Lot #: 20SE2108, exp. date: 10/31/2023; Lot #: 23JU2115, exp. date: 10/31/2023; Lot #: 28JY2101, exp. date: 10/31/2023; Lot #: 30JY2101, exp. date: 10/31/2023; Lot #: 05JA2212, exp. date: 3/31/2024; Lot #: 13DE2130, exp. date: 3/31/2024; Lot #: 21OC2111, exp date: 1/31/2024; Lot #: 17NO2116, exp. date: 3/31/2024; Lot #: D0122K, exp. date: 6/30/2024; Lot #: I1422N, exp. date: 9/30/2024; Lot #: I2721B, exp. date: 1/31/2024; Lot #: H1221Z, I0121J or J0622X, exp. date: 10/31/2023; Lot #: J0674153-010923, exp. date: 01/31/2024; Lot #: J0649447-092822, exp. date: 10/31/2023; Lot #: J0644887-090722, exp. date: 09/30/2023; Lot #: J0627309-062222, exp. date: 06/30/2023; Lot #: J0622569-060222, exp. date: 06/30/2023; Lot #: B1646259-041222, exp. date: 04/30/2023; Lot #: B2032846-122722, exp. date: 01/31/2025; Lot #: B2018675-121722, exp. date: 05/31/2025; Lot #: B1708230-060122 or B1709748-060122, exp. date: 06/30/2023; Lot #: B1692572-051822, exp. date: 05/31/2023; Lot #: B1803110-081122, exp. date: 12/31/2024; Lot #: B1820672-082422 or B1814883-082022, exp. date: 09/30/2024.

JARDIANCE (empagliflozin) tablets, 25 mg, 30- or 90-count bottles. Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company. Lot #: E61835, exp. date: JUN 2025.

Montelukast sodium tablets; 10 mg; 30-, 60- or 90-count bottle. Packaged and Distributed By: Direct Rx or Manufactured by: Accord Healthcare, Inc. Lot #: 20JU2211, exp date: 5/31/2024; Lot #: 25JU2128, exp. date: 12/31/2023; Lot #: 13SE2132, exp. date: 12/31/2023; Lot #: 25JU2133, exp. date: 12/31/2023; Lot #: 16JU2127, exp. date: 12/31/2023; Lot #: 18MY2126, exp. date: 12/31/2023; Lot #: 10JU2111, exp. date: 12/31/2023; Lot #: 14SE2111, exp. date: 1/31/2024; Lot #: 14JY2115, exp. date: 1/31/2024; Lot #: 25OC2113, exp. date: 2/29/2024; Lot #: 21SE2227, exp. date: 2/29/2024; Lot #: 10DE2123, exp. date: 3/31/2024; Lot #: 22NO2115, exp. date: 3/31/2024; Lot #: 21JA2202, exp. date: 4/30/2024; Lot #: 29DE2110, exp. date: 4/30/2024; Lot #: 28FE2227, exp. date: 4/30/2024; Lot #: 06JU2208, exp. date: 5/31/2024; Lot #: 30MA2229, exp. date: 5/31/2024; Lot #: 30AU2216, exp. date: 6/30/2024; Lot #: 23NO2203, exp. date: 6/30/2024; Lot #: 14DE2216, exp. date: 7/31/2025; Lot #: 12JA2305, exp. date: 7/31/2025; Lot #: F3021D, exp. date: 12/31/2023, Lot #: L0722T, exp. date: 5/31/2025; Lot#: F1021I, exp. date: 12/31/2023; Lot #: H1721R, exp. date: 12/31/2023, Lot #: L0722E, exp. date: 5/31/2025.

Pravastatin sodium tablets, 20 mg, 90-count bottle. Manufactured for: Accord Healthcare, Inc. Lot #: F1021I or H3122J, exp. date: 4/30/2024.

Ropinirole tablets; 0.25, 0.5, 1 or 2 mg; 30-, 90- or 190-count bottle. Packaged and Distributed by: Direct Rx or Repackaged by: RemedyRepack Inc. Lot #: 21JU2210, exp. date: 7/31/23; Lot #: 22JU2216, exp. date: 8/31/23; Lot #: B1789178-080122, exp. date: 07/31/2023; Lot #: B1675475-050522, exp. date: 05/31/2023; Lot #: B1630017-040122, exp. date: 04/30/2023.

Rosuvastatin tablets; 5, 10 or 40 mg; 30-, 45- or 90-count bottle. Manufactured: Accord Healthcare, Inc., or Repackaged by: RemedyRepack Inc. Lot #: F2022N, exp. date: 2/29/2024; Lot #: F0322I, exp. date: 8/31/2023; Lot #: J1322H, exp. date: 2/29/2024; Lot #: K0222N, exp. date: 6/30/2024; Lot #: L2322D or L2822J, exp. date: 7/31/2025; Lot #: A1723C, exp. date: 8/31/2025; Lot #: A1922B, exp. date: 6/30/2024; Lot #: D0622M or F2922I, exp. date: 7/31/2024; Lot #: G3021L, exp. date: 1/31/2024; Lot #: H2622P or J0722C, exp. date: 10/31/2024; Lot #: J0668398-121422, exp. date: 12/31/2023; Lot #: J0661225-111522 or J0654053-101822, exp. date: 11/30/2023; Lot #: J0646383-091422, exp. date: 09/30/2023; Lot#: J0674788-011123, exp. date: 01/31/2024; Lot #: J0664118-112922 or J0664118-112922, exp. date: 12/31/2023; Lot #: J0653727-101722, exp. date: 10/31/2023. Lot #: B2057931-011223, exp. date: 07/31/2025; Lot #: B2075815-012523, exp. date: 09/30/2025; Lot #: B2011634-121322, exp. date: 07/31/2025; Lot #: B1970205-112022, exp. date: 06/30/2024; Lot #: B1862598-092022, exp. date: 03/31/2024; Lot #: B2077226-012523 or B2070444-012023, exp. date: 07/31/2025; Lot #: B2038806-123022, B2014185-121422 or B1925528-102522, exp. date: 07/31/2025. Lot #: B2080829-012823, B1938007-110222 or B2038746-123022, exp. date: 07/31/2025.

Simvastatin tablets; 5, 10, 20, 40 or 80 mg; 30-, 60- or 90-count bottle. Packaged and Distributed By: Direct Rx or Manufactured for: Accord Healthcare, lnc., or Repackaged by: RemedyRepack Inc. Lot #: 03JA2209, 28FE2225, 28AP2211 or 07AP2203, exp. date: 6/30/23; Lot #: 05AU2206, exp. date: 10/31/23; Lot #: 30MA2213, exp. date: 6/30/23; Lot #: 10DE2124, exp. date: 3/31/23; Lot #: 15MA2224, exp. date: 5/32/23; Lot #: 27JA2229, exp. date: 3/31/23; Lot #: 09JA2312, exp. date: 2/28/2025; Lot #: 22OC2111, exp. date: 1/31/2023; Lot #: 13OC2120, exp. date: 3/31/2023; Lot #: 16JY2104, exp. date: 12/31/2023; Lot #: 09AU2125, exp. date: 1/31/2024; Lot #: 28JY2125, exp. date: 1/31/2024; Lot #: 23SE2115, exp. date: 3/31/2024; Lot #: 23SE2115, exp. date: 3/31/2024; Lot #: 07JA2211, exp. date: 5/31/2024; Lot #: 27JA2214, exp. date: 5/31/2024; Lot #: 15AP2224, exp. date: 6/30/2024; Lot #: 24MA2221, exp. date: 6/30/2024; Lot #: 16AU2214, exp. date: 6/30/2024; Lot #: 28AP2212, exp. date: 7/31/2024; Lot #: 24MA2230, exp. date: 7/31/2024; Lot #: 11JA2203, exp. date: 3/31/2023; Lot #: 02FE2217, exp. date: 2/28/2023; Lot #: 10DE2126, exp. date: 2/28/2023; Lot #: 25MA2201, exp. date: 5/31/2023; Lot #: 28FE2230, exp. date: 5/31/2023; Lot #: C2222P, D1522L, E3122D or G2522J, exp. date: 9/30/2023; Lot #: J1222R, exp. date: 10/31/2023; Lot #: B0222S, exp. date: 2/29/2024; Lot #: F1121B or G2721L, exp. date: 11/30/2023; Lot #: A0923R, exp. date: 2/28/2025; Lot #: A1222K or B1822C, exp. date: 5/31/2024; Lot #: C3022D or F2322V, exp. date: 6/30/2024; Lot #: H1522H, exp. date: 8/31/2024; Lot #: I1621O, exp. date: 1/31/2024; Lot #: I2222G or J1822R, exp. date: 9/30/2024; Lot #: L1621N, exp. date: 5/31/2024; Lot #: F0822Q, exp. date: 6/30/2024, Lot #: I0122J, exp. date: 8/31/2024, Lot #: L0821C, exp. date: 5/31/2024; Lot #: I1521P, exp. date: 1/31/2024; Lot #: J1322R, exp. date: 9/30/2024; Lot #: J1821H, exp. date: 2/29/2024; Lot #: B0922G, exp. date: 5/31/2023; Lot #: F0322G, exp. date: 7/25/2024; Lot #: H2622M, exp. date: 8/31/2024; Lot #: J1422B or K0722G, exp. date: 10/31/2024; Lot #: L1922A, exp. date: 2/28/2025; Lot #: F2922S, exp. date: 8/31/2023; Lot #: H0322G, exp. date: 7/31/2023; Lot #: A1322I, exp. date: 3/31/2023; Lot #: H1122C, exp. date: 8/31/2024; Lot #: J0675206-011223 or J0669260-121922, exp. date: 01/31/2024; Lot #: J0656820-103122 or J0647161-091722, exp. date: 09/30/2023 or 11/30/2023; Lot #:J0621491-052722, exp. date: 06/30/2023; Lot #: J0638138-080822, exp. date: 08/31/2023; Lot #: J0610887-041122, exp. date: 04/30/2023. Lot #: B1887315-100422, exp. date: 02/28/2024; Lot #: B1829906-083122 or B1769715-071622, exp. date: 09/30/2023; Lot#: B1906605-101422, exp. date: 02/28/2024; Lot #: B1965118-111622, exp. date: 02/28/2025; Lot #: J0656821-103122, exp. date: 11/30/2023; J0638547-080922, Exp. Date 08/31/2023; J0633575-071822, Exp. Date 07/31/2023 Lot #: b): B1965081-111622, Exp. Date 03/31/2025; B1857922-091922, B1765298-071322, B1786319-072922, B1706842-053122, Exp. Date 04/30/2023; B2003311-120822, Exp. Date 04/30/2025; B1955679-111122, Exp. Date 02/28/2025; B1878942-092922, Exp. Date 11/30/2024; B1823203-082622. Exp. Date 10/31/2024; B1706843-053122, Exp. Date 05/31/2023.

Tadalafil tablets, 5 or 20 mg, 7- or 30-count bottle. Manufactured for: Accord Healthcare, lnc., or Repackaged by: RemedyRepack Inc. Lot #: C0822E, exp. date: 1/31/2024; Lot #: F1121B, exp. date: 1/31/2024; Lot #: G2721L, exp. date: 1/31/2024; Lot #: B1635780-040522, exp. date: 04/30/2023.